The serotonin 1B receptor: A new target for depression therapeutics?

James W. Murrough; Alexander Neumeister

doi:10.1016/j.biopsych.2011.02.020

The serotonin 1B receptor: A new target for depression therapeutics?

Research output: Contribution to journal › Comment/debate

13 Scopus citations

Original language	English
Pages (from-to)	714-715
Number of pages	2
Journal	Biological Psychiatry
Volume	69
Issue number	8
DOIs	https://doi.org/10.1016/j.biopsych.2011.02.020
State	Published - 15 Apr 2011

Access to Document

10.1016/j.biopsych.2011.02.020

Cite this

@article{c91eda24143a4bbb9f9a0d65e9ee998d,

title = "The serotonin 1B receptor: A new target for depression therapeutics?",

author = "Murrough, {James W.} and Alexander Neumeister",

note = "Funding Information: Dr. Neumeister receives grant support from the National Institutes of Health R21 MH081103 (ARRA), R21 MH085627 , and RL1 AA017540 and a National Alliance for Research on Schizophrenia and Depression (NARSAD) 2007 Independent Investigator Award . Dr. Murrough receives research support from NARSAD and salary support from a research education grant from AstraZeneca to Mount Sinai School of Medicine. The content is solely the responsibility of the authors and does not represent the official views of the National Institute of Mental Health of the National Institutes of Health or NARSAD.",

year = "2011",

month = apr,

day = "15",

doi = "10.1016/j.biopsych.2011.02.020",

language = "English",

volume = "69",

pages = "714--715",

journal = "Biological Psychiatry",

issn = "0006-3223",

publisher = "Elsevier USA",

number = "8",

}

TY - JOUR

T1 - The serotonin 1B receptor

T2 - A new target for depression therapeutics?

AU - Murrough, James W.

AU - Neumeister, Alexander

N1 - Funding Information: Dr. Neumeister receives grant support from the National Institutes of Health R21 MH081103 (ARRA), R21 MH085627 , and RL1 AA017540 and a National Alliance for Research on Schizophrenia and Depression (NARSAD) 2007 Independent Investigator Award . Dr. Murrough receives research support from NARSAD and salary support from a research education grant from AstraZeneca to Mount Sinai School of Medicine. The content is solely the responsibility of the authors and does not represent the official views of the National Institute of Mental Health of the National Institutes of Health or NARSAD.

PY - 2011/4/15

Y1 - 2011/4/15

UR - http://www.scopus.com/inward/record.url?scp=79953182688&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2011.02.020

DO - 10.1016/j.biopsych.2011.02.020

M3 - Comment/debate

C2 - 21447414

AN - SCOPUS:79953182688

SN - 0006-3223

VL - 69

SP - 714

EP - 715

JO - Biological Psychiatry

JF - Biological Psychiatry

IS - 8

ER -